Hsieh-Ting Lin
    • Create new note
    • Create a note from template
      • Sharing URL Link copied
      • /edit
      • View mode
        • Edit mode
        • View mode
        • Book mode
        • Slide mode
        Edit mode View mode Book mode Slide mode
      • Customize slides
      • Note Permission
      • Read
        • Only me
        • Signed-in users
        • Everyone
        Only me Signed-in users Everyone
      • Write
        • Only me
        • Signed-in users
        • Everyone
        Only me Signed-in users Everyone
      • Engagement control Commenting, Suggest edit, Emoji Reply
      • Invitee
    • Publish Note

      Share your work with the world Congratulations! 🎉 Your note is out in the world Publish Note

      Your note will be visible on your profile and discoverable by anyone.
      Your note is now live.
      This note is visible on your profile and discoverable online.
      Everyone on the web can find and read all notes of this public team.
      See published notes
      Unpublish note
      Please check the box to agree to the Community Guidelines.
      View profile
    • Commenting
      Permission
      Disabled Forbidden Owners Signed-in users Everyone
    • Enable
    • Permission
      • Forbidden
      • Owners
      • Signed-in users
      • Everyone
    • Suggest edit
      Permission
      Disabled Forbidden Owners Signed-in users Everyone
    • Enable
    • Permission
      • Forbidden
      • Owners
      • Signed-in users
    • Emoji Reply
    • Enable
    • Versions and GitHub Sync
    • Note settings
    • Engagement control
    • Transfer ownership
    • Delete this note
    • Save as template
    • Insert from template
    • Import from
      • Dropbox
      • Google Drive
      • Gist
      • Clipboard
    • Export to
      • Dropbox
      • Google Drive
      • Gist
    • Download
      • Markdown
      • HTML
      • Raw HTML
Menu Note settings Sharing URL Create Help
Create Create new note Create a note from template
Menu
Options
Versions and GitHub Sync Engagement control Transfer ownership Delete this note
Import from
Dropbox Google Drive Gist Clipboard
Export to
Dropbox Google Drive Gist
Download
Markdown HTML Raw HTML
Back
Sharing URL Link copied
/edit
View mode
  • Edit mode
  • View mode
  • Book mode
  • Slide mode
Edit mode View mode Book mode Slide mode
Customize slides
Note Permission
Read
Only me
  • Only me
  • Signed-in users
  • Everyone
Only me Signed-in users Everyone
Write
Only me
  • Only me
  • Signed-in users
  • Everyone
Only me Signed-in users Everyone
Engagement control Commenting, Suggest edit, Emoji Reply
Invitee
Publish Note

Share your work with the world Congratulations! 🎉 Your note is out in the world Publish Note

Your note will be visible on your profile and discoverable by anyone.
Your note is now live.
This note is visible on your profile and discoverable online.
Everyone on the web can find and read all notes of this public team.
See published notes
Unpublish note
Please check the box to agree to the Community Guidelines.
View profile
Engagement control
Commenting
Permission
Disabled Forbidden Owners Signed-in users Everyone
Enable
Permission
  • Forbidden
  • Owners
  • Signed-in users
  • Everyone
Suggest edit
Permission
Disabled Forbidden Owners Signed-in users Everyone
Enable
Permission
  • Forbidden
  • Owners
  • Signed-in users
Emoji Reply
Enable
Import from Dropbox Google Drive Gist Clipboard
   owned this note    owned this note      
Published Linked with GitHub
Subscribed
  • Any changes
    Be notified of any changes
  • Mention me
    Be notified of mention me
  • Unsubscribe
Subscribe
# 內科值班04 ## Sepsis 敗血症 ### 定義:**感染** + **Organ Dysfunction** **(SOFA≥2)**, not SIRS now 重點:內科急症,如果懷疑,盡早使用廣效抗生素 前言:當一個病人(1)發燒 或(2)有既存感染+臨床(vital signs, UOP, GCS)有變化,都要評估有無sepsis的可能性 ### **懷疑sepsis先算qSOFA (≥兩項):** 1. 意識 GCS<15 2. 血壓 SBP≤100 3. 呼吸 RR≥22 ### **如果qSOFA≥兩項,進入Hour-1 Bundle流程** **1. 抽血:** * CBC/DC, BCS, ABG(?), **Lactate, 兩套B/C**, U/A, U/C, S/C, CXR **2. 廣效抗生素(一小時內給,依腎功能調整劑量):** * 本院首選tazocin,已經在用的話升階meropenem * 懷疑MRSA感染再加Vancomycin or teicoplanin (腎功能差選teico,前三天都不用腎調) * 感染科會診單可暫存,先把醫囑開出去,病歷後面再慢慢打 **3. 點滴(血壓掉 或 lactate>4):** * 先給N/S 500ml (病房有可以直接給),再給L/R (優於N/S) * 總量30ml/kg in 3hr,但如果給到要喘起來還是問一下二線比較好 (eg. 年紀大或有HF) * Vital signs不穩的話要放Foley,記I/O,Hold 血壓藥 **4. 醫囑(抽血、抗生素、點滴)先開完,接下來好好survey,找infection focus** * Hx (Underlying dz, Associated s/s) + PE (from head to toe) + Lab (eg. 之前的Culture, CXR) * Sourse control (跟二線或原主治討論), eg. 切CT排除IAI, APN+水腎放 PCN, calculous cholecystitis 做 ERCP, abscess 做 aspiration 或 drainage... **5. 升壓劑 (1st line: levophed)**: **通知二線,狀況不穩定且需要下ICU** * 使用時機: 輸液無法維持MAP≥65 (CRT>2s, UOP<0.5ml/kg/hr, AMS 也要懷疑shock) * 確認DNR status,有沒有拒升壓藥 ``` [Duty note] I was called for ___. ___-year-old ___ with underlying ___, admitted for ___. The patient developed ___ at ___, accompanied by ___, ___ Vital Signs: GCS: PE: UOP: Lab: Previous culture and abx: CXR: # Fever/Hypotension/Dyspnea with qSOFA(___/3), favor sepsis with response to fluid resuscitation/ impending septic shock refractory to fluid resuscitation, septic workup showed ___, infection focus: peumonia, UTI, IAI, catheter-related infection, soft tissue infection... - empirical ___ was administered, pending for culture and ID consultation - fluid resuscitation to keep MAP≥65, transfer to ICU if unstable hemodynamic status / for refracotry to keep MAP≥65 after fluid resuscitation, transfer to ICU for unstable hemodynamic status - consider sourse control with___ - DNR status:___ ``` **施老大:** 值班懷疑sepsis,抽完血抗生素早點上,水給夠,剩下的交給大人處理 **SOFA (影響重要器官)** 用計算機算,但在ICU比病房實用 1. **心** BP (MAP or 升壓劑使用) 1. **肺** PaO2/FiO2 1. **腦** GCS 1. **肝** T-bili 1. **腎** Cr and UOP 1. **血** PLT ### **Septic shock** **定義:** sepsis + 需vessopressor維持MAP≥65 + Serum lactate >2 mmol/L ## Pneumonia **定義:** * Pneumonia: s/s (fever, cough, purulent sputum, dyspnea) + new infiltrate on CXR/CT * CAP (醫院外感染)/ HAP (住院後≥48hr)/ VAP (插管後≥48hr) * Lung empyema: pus 積在 pleural space * Lung abscess: 肺實質壞死 + cavitation * Aspiration pneumonitis: 吸入胃內容物後的急性肺損傷,細菌感染可在24-72hr後發生 **Hx:** Fever, cough, purulent sputum, dyspnea, aspiration, TOCC(住院/安養機構), COVID (確診/疫苗) **PE:** Vital signs, SpO2, chest exam, extra-pulmonary signs? **Lab:** * **必做:** CBC/DC, BCS (±lactate), 兩套B/C (before abx!), ±ABG CXR (PA+LAT) Sputum culture (Gram stain & Aerobic, Legionella/S. Pneumo urine Ag, ±AFB ± Mycobact.) * **考慮:** COVID PCR, Influenza Ag Pneumonia panel? (high risk of aspiration, refractory to tx?) Chest CT (懷疑細菌性肺炎以外的診斷, eg. fungal/viral/chemical/PE/CHF/ARDS/DAH/ILD, 懷疑ILD要做HRCT) BAL (懷疑VAP或Atypical pneumonia) PCT (<0.25可停abx, 免疫不全跟CKD不適用, 偽陽: CPR, shock, burns, surgery) **Severity (qSOFA, CURB65, PSI)** * CURB-65: confusion, BUN>20, RR>30, BP<90/60, Age>65 (>2: admit, >3: ICU) * PSI(按計算機): age, sex, 住機構, 共病, vital signs, AMS, lab (pH, BUN, Na, Glu, Hct, PaO2, pleural effusion) **Management** * Sepsis → Early Abx ; Cover pathogen accordingly * **CAP (5-7d) → IV Augmentin + 3d of Oral Azithromycin** ± Vanco if MRSA carrier (Tazocin + azithromycin if recent Hx of PsA肺炎, 住院, iv abx) * **HAP (7d) → Tazocin + 3d of Azithromycin** ± Vanco if MRSA carrier * If severe → Tazocin + Ciproxin/Levofloxicin/Amikacin + Vanco * Consider PJP/Flu/Fungus/Autoimmune/Tumor/Treat-relate? ## Urinary tract infection * Voiding U/C >10^5 * Upper or lower; complicated or uncomplicated? * 排除其他疾病 (pyuria ≠ UTI): eg. Appen? Psoas abscess? **Dx** * Hx: LUTs?, fever, rigors, malaise, back pain, GI s/s (if APN) * PE: Vitals, CV angle knocking, DRE if man * Labs: CBC,B/C,UA,U/C, ± Echo: hydronephrosis? Stone? BPH? * WBC太低的病人不會有pyuria,U/C 記得直接留 * CT A/P: severely illness, obstruction, persisted sx after 48-72hr of appropriate abx **Management** - Hydration - 如果有Foley,拔掉或重放 - 沒症狀的話只有孕婦、腎移植跟做泌尿科procedure前要治療 (狀況差或意識不清除外) - 經驗性抗生素 (記得留U/C, B/C,記得看之前culture結果,記得腎調) - 下泌尿道症狀 (simple or uncomplicated): **Cefazolin or cefuroxime** - 發燒冷顫、後腰痛或男生DRE有壓痛 (upper or complicated): **Ceftriaxone** - 懷疑院內感染: **Ceftazidime** (+pseudo) - Critical illness: **Tazocin** (+enterococcus) - If sepsis + hydronephrosis → consider PCN (跟二線討論) ## Skin and soft tissue infection * Carbuncle (毛囊), erysipelas (真皮), cellulitis (皮下組織) * **急症要開刀: Necrotizing fasciitis, Fournier gangrene, Ludwig angina** **DX:** - Hx: TOCC, Pain+progress?, sea/river/cat/dog - PE: skin erythema (with sharp margin in erysipelas, edema, warmth, petechiae, hemorrhage, superficial bullae, crepitant and gangrenous​) - **懷疑Necrotizing fasciitis** - **crepitant 捏氣泡紙的聲音/ bullae/ necrosis or ecchymosis** - **不成比例的劇烈疼痛/ 對疼痛的感覺減弱/ 快速進展/ 低血壓/ systemic illness** - **懷疑深部感染:** - erythema without sharp margins 邊緣不清楚 - edema extends beyond the visible erythema 水腫範圍大於紅斑 - 眼肌麻痺 ophthalomoplagia/ 眼球突出protosis/ 眼球運動疼痛 - 牙關緊閉trismus/ 斜頸/ 聲音低沉不清楚 muffled voice - 流口水/ 唾液積聚/ 喘鳴/ 吞嚥困難/ 吞嚥痛 - Labs: CBC/CRP, pus culture, B/C; lactate, AST, CK (for deep tissue necrosis); PT/aPTT if surgical indicated; CT if fasciitis **Management** * **Consider Necrotizing fasciitis!! → Surgical Debridement (叩二線/外科/放射科)** → Cefepime/Tazo ± Vancomycin ± clindamycin ± Doxy * 特殊情況: 懷疑深部感染/臉部危險三角 (叩二線) * **Erysipelas: cefazolin or ceftriaxone (出院: Amoxicillin or Cephalexin)** * **Cellulitis: oxacillin or cefazolin (出院: Dicloxacillin or Cephalexin)** * Consider MRSA if poor response * 懷疑abscess -> sono抽吸或引流 ``` 感染症抗生素使用可參考: uCentral>> 醫療專區(contents) >> 3. Infectious Diseases Guidelines (感染症診治及用藥指引) UpToDate ``` ## Acute heart failure 鑑別診斷: 肺栓塞、氣喘發作、肺炎、ARDS、pericardial tamponade 多因呼吸困難或氧合能力不佳而就醫 找原因: * 飲食不當或服藥依從性不佳 (40%) * 心肌缺血/梗塞 (10-15%); myocarditis * 腎衰竭 (↑ preload) * 高血壓、AS (↑ left-sided afterload) * 藥物: βB, CCB, NSAIDs, TZDs, anthracyclines, trastuzumab, EtOH * 心律不整、瓣膜疾病、Aortic dissection * COPD、PE、Anemia、壓力、感染、甲狀腺亢進/低下 臨床表現: * Acute dyspnea, orthopnea, tachypnea, tachycardia, and hypertension * 低血壓反映疾病較嚴重,需要評估周邊組織及重要器官的灌流 (GCS, UOP, CRT) * PE: JVE, diffuse rales, wheezing (cardiac asthma), S3/S4, pitting edema * ECG: ACS, Arrythmia, LVH * CXR: pulmonary edema, cardiomegaly, pneumonia; CXR正常不能排除ADHF * Lab: CBC/DC, 肝腎, Na/K/Mg/Cl/HCO3-, Cardiac enzymes, NT-proBNP, thyroid function, lactate if suspect shock, D-dimer if unlikely PE (likely PE 要做CTA) * 心臟超音波 Management: * 監測血氧、VS、心律 * 給氧 if SpO2 <90%, 坐直 * Furosemide 40 mg IV,血壓高沒有shock可用NTG * 找上述原因並治療 * Af with RVR: 藥物降HR, new onset 考慮 Cardioversion (ACLS) * 已知HF * HFrEF (LVEF<40%) 合併 cardiogenic shock: 停用長期使用的βB,上強心劑 * HFpEF (LVEF≧50%) 合併 cardiogenic shock: βB + IV fluid + 升壓劑 + 心超 (排除 acute AR/MR) * LVEF未知但合併cardiogenic shock: 強心劑 +/- 升壓劑 + 心超 HFrEF四支柱: ACEi/ARB/ARNi + βB + MRA + SGLT2i ## COPD AE 特徵: Diffuse wheezing, 桶狀胸, tachypnea, tachycardia, 吸菸 >20 pack years 嚴重: 用呼吸輔助肌、講話零碎/片段、無法躺平、冒汗/躁動、蹺蹺板呼吸、初始治療未能改善。 合併/加重: ACS, ADHF, PE, pneumonia, pneumothorax, sepsis Hx, PE and Labs * Infection(sputum↑)? Chest pain? Vital signs, wheezes; * CBC,BCS,CRP,ABG(CO2); CXR, ± CTPA if PE suspected, influenza? Management * Primary ABC,血氧目標: SpO2: 88-92% or PaO2: 60-70 mmHg * 評估需不需要插管 (嚴重度及病家意願),要插或看起來快插->叩二線 * A (Atrovent) + B (Ventolin) INHL Q4HPRN * Methylprednisolone 60-125 mg IV, Q6H-Q12H,記得驗血糖 * BIPAP if CO2 retention (禁忌: AMS、無法保護airway、high aspiration risk) * Intubate if AMS, with RSI (eg, etomidate, ketamine, or propofol) * Abx: Ceftriaxone 2g QD or Tazocin 4.5gm Q6H if cover Peudo ## DVT & PE ### Risk factors * Virchow’s triad * Stasis: 臥床少活動, CHF, 三個月內中風過, 坐飛機超過六小時 * 血管內皮受損: trauma, surgery, prior DVT/PE, central line * Thrombophilia: genetic disorders, 避孕藥, HRT * Malignancy * 肥胖、抽菸、急性感染、產後 ### DVT * 小腿或患肢有紅/腫/熱/痛 * Homan’s sign (dorsiflexion 更痛) ### PE * 喘 (50%), 肋膜性胸痛 (40%), 咳嗽 (20%), 咳血 (10%) * ↑ RR (>70%), crackles (50%), ↑ HR (30%) * fever, cyanosis, pleural friction rub, loud P2 * Massive: syncope, HoTN, ↑JVP * ECG: sinus tachycardia, S1Q3T3 (<10%) * CXR: 正常 (12%), 肺塌陷, 肋膜積液, Hampton hump (wedge-shaped, pleural-based opacification), Westermark sign (栓塞處distal端的肺紋變少/radiolucency) * Lab: ABG (hypoxemia, ↑ A-a gradient), D-dimer, ±TnI ±NT-proBNP * 心超: RV strain, D-shape LV ### **Approach to suspected DVT (Simplified Wells Pretest Probability Scoring of DVT)** ![](https://i.imgur.com/56gzN53.png) ### **Approach to suspected PE (Modified Wells Pretest Probability Scoring for PE)** ![](https://i.imgur.com/ndYlXiD.png) ### Management * 穩定 vital signs (O2, IV, vessopressor) * 不穩定: 轉ICU 打tPA * 穩定: heparin/LMWH/DOAC/warfarin * IVC filter if contraindicated to anticoagulants * Refractory → Catheter(EKOS為導管超音波震波溶栓) or surgical thrombectomy ## Clostridium difficile infection * Risk factors: 之前抗生素使用, 高強度化療, PPI, GI surgery, HSCT, etc. * 特徵: ≥3 unformed stools in 24 hours, 連續兩天 (排除ileus) * 診斷: * Stool CDI toxin PCR * 大便未成形才要驗, 太水流不到檢體可用rectal swab * PCR (+) toxin (-) 不一定要治療 * CBC/DC and BCS if no data, B/C if fever * CT if megacolon/unstable * 治療 (依嚴重程度): * Non-severe (WBC <15K and SCr <1.5 or Cr 上升 <50%) * Metronidazole 500mg PO/IV TID * Severe (WBC ≥15K or SCr ≥1.5 or Cr 上升 ≥50%) * Vancomycin 125mg PO QID * Fulminant colitis (HoTN, ileus, toxic megacolon, perforation, need colectomuy or ICU) * Vancomycin 500mg PO/NG/Rectal/colostomy QID + Metronidazole 500mg IV Q8H + surgical consultation ## Acute pancreatitis Enzymes → autodigestion; Lipase↑ ± Imaging, 排除其他 3rd space fluid; ARDS, hemorrhage, infected pseudocyst Hx, PE and Labs * Abd pain(worse when lying), gallstone/alcohol/Drugs? * SIRS, abd PE; CBC+ B/C(if fever) + Lipase/BUN, CXR ± CT Management * BISAP score for prognosis * NPO + fluid resuscitation +early feeds ; follow up BUN * ERCP for gallstone pancreatitis (in 24 hours) * ABx if signs of infection/shock

Import from clipboard

Paste your markdown or webpage here...

Advanced permission required

Your current role can only read. Ask the system administrator to acquire write and comment permission.

This team is disabled

Sorry, this team is disabled. You can't edit this note.

This note is locked

Sorry, only owner can edit this note.

Reach the limit

Sorry, you've reached the max length this note can be.
Please reduce the content or divide it to more notes, thank you!

Import from Gist

Import from Snippet

or

Export to Snippet

Are you sure?

Do you really want to delete this note?
All users will lose their connection.

Create a note from template

Create a note from template

Oops...
This template has been removed or transferred.
Upgrade
All
  • All
  • Team
No template.

Create a template

Upgrade

Delete template

Do you really want to delete this template?
Turn this template into a regular note and keep its content, versions, and comments.

This page need refresh

You have an incompatible client version.
Refresh to update.
New version available!
See releases notes here
Refresh to enjoy new features.
Your user state has changed.
Refresh to load new user state.

Sign in

Forgot password

or

By clicking below, you agree to our terms of service.

Sign in via Facebook Sign in via Twitter Sign in via GitHub Sign in via Dropbox Sign in with Wallet
Wallet ( )
Connect another wallet

New to HackMD? Sign up

Help

  • English
  • 中文
  • Français
  • Deutsch
  • 日本語
  • Español
  • Català
  • Ελληνικά
  • Português
  • italiano
  • Türkçe
  • Русский
  • Nederlands
  • hrvatski jezik
  • język polski
  • Українська
  • हिन्दी
  • svenska
  • Esperanto
  • dansk

Documents

Help & Tutorial

How to use Book mode

Slide Example

API Docs

Edit in VSCode

Install browser extension

Contacts

Feedback

Discord

Send us email

Resources

Releases

Pricing

Blog

Policy

Terms

Privacy

Cheatsheet

Syntax Example Reference
# Header Header 基本排版
- Unordered List
  • Unordered List
1. Ordered List
  1. Ordered List
- [ ] Todo List
  • Todo List
> Blockquote
Blockquote
**Bold font** Bold font
*Italics font* Italics font
~~Strikethrough~~ Strikethrough
19^th^ 19th
H~2~O H2O
++Inserted text++ Inserted text
==Marked text== Marked text
[link text](https:// "title") Link
![image alt](https:// "title") Image
`Code` Code 在筆記中貼入程式碼
```javascript
var i = 0;
```
var i = 0;
:smile: :smile: Emoji list
{%youtube youtube_id %} Externals
$L^aT_eX$ LaTeX
:::info
This is a alert area.
:::

This is a alert area.

Versions and GitHub Sync
Get Full History Access

  • Edit version name
  • Delete

revision author avatar     named on  

More Less

Note content is identical to the latest version.
Compare
    Choose a version
    No search result
    Version not found
Sign in to link this note to GitHub
Learn more
This note is not linked with GitHub
 

Feedback

Submission failed, please try again

Thanks for your support.

On a scale of 0-10, how likely is it that you would recommend HackMD to your friends, family or business associates?

Please give us some advice and help us improve HackMD.

 

Thanks for your feedback

Remove version name

Do you want to remove this version name and description?

Transfer ownership

Transfer to
    Warning: is a public team. If you transfer note to this team, everyone on the web can find and read this note.

      Link with GitHub

      Please authorize HackMD on GitHub
      • Please sign in to GitHub and install the HackMD app on your GitHub repo.
      • HackMD links with GitHub through a GitHub App. You can choose which repo to install our App.
      Learn more  Sign in to GitHub

      Push the note to GitHub Push to GitHub Pull a file from GitHub

        Authorize again
       

      Choose which file to push to

      Select repo
      Refresh Authorize more repos
      Select branch
      Select file
      Select branch
      Choose version(s) to push
      • Save a new version and push
      • Choose from existing versions
      Include title and tags
      Available push count

      Pull from GitHub

       
      File from GitHub
      File from HackMD

      GitHub Link Settings

      File linked

      Linked by
      File path
      Last synced branch
      Available push count

      Danger Zone

      Unlink
      You will no longer receive notification when GitHub file changes after unlink.

      Syncing

      Push failed

      Push successfully